Loading…
COVID–19 Price Gouging Prevention Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
COVID–19 Price Gouging Prevention Act This bill makes it unlawful for any person to sell or offer for sale a consumer good or service during a public health emergency resulting from COVID-19 (i.e., coronavirus disease 2019) at a price that (1) is unconscionably excessive, and (2) indicates that the seller is using the circumstances related to the public health emergency to increase prices unreasonably.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (9)
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2020 · fourth_quarter · Consumer Issues/Safety/Products
price gouging, organized retail crime (ORC), marketplace transparency - S. 3431, HR. 6472; COVID-19/CARES Act; HR 7756 - INFORM Consumers Act
Client expense: $590,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Telecommunications & Information Administration (NTIA), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Consumer Issues/Safety/Products
Data Privacy and Security - communications of retail views regarding data privacy and security issues, including IoT device security and proposed legislation affecting the collection, use, security and disclosure of personal information and self-regulatory privacy programs providing protection for consumers, including: S. 2968, Consumer Online Privacy Rights Act; S. 3456, Consumer Data Privacy & Security Act; S. 3663, COVID-19 Consumer Data Protection Act; S. 3749, Public Health Emergency Privacy Act; S. 3861, Exposure Notification Privacy Act; S. 4626, the Setting an American Framework to Ensure Data Access, Transparency, and Accountability (SAFE DATA) Act; Draft [Carper-Blunt] Data Security and Breach Notification Act (not yet introduced in Senate); H.R. 2013, Information Transparency & Personal Data Control Act; H.R. 4978, Online Privacy Act; H.R. 6866, Public Health Emergency Privacy Act; and House Energy and Commerce Committee draft privacy legislation. Transatlantic Data Transfers and Related EU Data Regulatory Issues - communication of retail views regarding U.S. policy with respect to the regulation of transfers of personal data from EU to U.S., including discussion of the invalidated EU-U.S. Privacy Shield, the proposed EU modernization of and recommendations on the use of modernized Standard Contractual Clauses (SCCs) for transatlantic data transfers, the White Paper on SCCs issued by the Department of Commerce, and on-going EU-U.S. relations on these and related data protection regulatory issues. Price-Gouging Issues - communications of retail views regarding price-gouging legislation, including: H.R. 6472, COVID-19 Price Gouging Prevention Act; S. 3574, Ending Price-Gouging During Emergencies Act; S. 3576, Disaster and Emergency Pricing Abuse Prevention Act; and Senate Commerce Committee draft price-gouging legislation. CPSC Oversight issues - communications regarding product safety issues; overall agency reviews on key issues.
Client expense: $1,660,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Consumer Product Safety Commission (CPSC), Equal Employment Opportunity Commission (EEOC), Federal Maritime Commission, Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Maritime Administration (MARAD), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Postal Service (USPS), U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Consumer Issues/Safety/Products
Issues that impact the cleaning products industry due to COVID-19 to foster public health and enable re-opening of businesses S.3574 - Ending Price-Gouging During Emergencies Act S. 3576/H.R.6457 - Disaster and Emergency Pricing Abuse Prevention Act H.R.6472 - COVID-19 Price Gouging Prevention Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 6472, COVID-19 Price Gouging Prevention Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Consumer Issues/Safety/Products
1. H.R. 6472, COVID-19 Price Gouging Prevention Act, entire bill
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Pension & Welfare Benefits Administration, Pension Benefit Guaranty Corporation (PBGC), SENATE, Social Security Administration (SSA)
2020 · third_quarter · Consumer Issues/Safety/Products
Data Privacy and Security - communications of retail views regarding data privacy and security issues, including IoT device security and proposed legislation affecting the collection, use, security and disclosure of personal information and self-regulatory privacy programs providing protection for consumers, including: S. 2968, Consumer Online Privacy Rights Act; S. 3456, Consumer Data Privacy & Security Act; S. 3663, COVID-19 Consumer Data Protection Act; S. 3749, Public Health Emergency Privacy Act; S. 3861, Exposure Notification Privacy Act; S. 4626, the Setting an American Framework to Ensure Data Access, Transparency, and Accountability (SAFE DATA) Act; Sens. Carper and Blunt staff discussion draft of Data Security and Breach Notification Act (not yet introduced); H.R. 2013, Information Transparency & Personal Data Control Act; H.R. 4978, Online Privacy Act; H.R. 6866, Public Health Emergency Privacy Act; and House Energy and Commerce Committee staff discussion draft of privacy legislation. Price-Gouging Issues - communications or retail views regarding price-gouging legislation, including: H.R. 6472, COVID-19 Price Gouging Prevention Act; S. 3574, Ending Price-Gouging During Emergencies Act; S. 3576, Disaster and Emergency Pricing Abuse Prevention Act; Sen. Moran staff discussion draft of price-gouging legislation; and Sen. Cantwell staff discussion draft of price-gouging legislation. CPSC Oversight issues - communications regarding data privacy issues; overall agency reviews on key issues.
Client expense: $1,400,000 · Firm income: Not reported
2020 · third_quarter · Consumer Issues/Safety/Products
price gouging, organized retail crime (ORC), marketplace transparency - S. 3431, HR. 6472; COVID-19/CARES Act; HR 7756 - INFORM Consumers Act
Client expense: $430,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Telecommunications & Information Administration (NTIA), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
2020 · third_quarter · Consumer Issues/Safety/Products
Issues that impact the cleaning products industry due to COVID-19 to foster public health and enable re-opening of businesses S.3574 - Ending Price-Gouging During Emergencies Act S. 3576/H.R.6457 - Disaster and Emergency Pricing Abuse Prevention Act H.R.6472 - COVID-19 Price Gouging Prevention Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Consumer Issues/Safety/Products
1. H.R. 6472, COVID-19 Price Gouging Prevention Act, entire bill
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Pension & Welfare Benefits Administration, Pension Benefit Guaranty Corporation (PBGC), SENATE, Social Security Administration (SSA)
2020 · third_quarter · Consumer Issues/Safety/Products
H.R. 6472, COVID-19 Price Gouging Prevention Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
H.R. 748, CARES Act H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 985: FAST Generics Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R.1730, Cancer Drug Parity Act of 2019 H.R. 4100: DISARM Act of 2019 - Provisions related to antimicrobial drug development H.R. 5239: Prescription Drug Price Reporting Act - Provisions related to prescription drug pricing transparency S1872/HR5076, Protecting Seniors Through Immunization Act H.R. 5668: MODERN Labeling Act of 2020 - Provisions related to prescription drug labeling H.R. 6019: Cure the Coronavirus Act - Provisions related to FDA prescription drug approvals H.R. 6080: Preventing Drug Shortages Act - Provisions related to prescription drug shortage reporting requirements H.R. 6222: Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6258: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity H.R. 6260: Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Coronavi-rus Patients Act of 2020 - Provisions related to FDA prescription drug marketing approvals H.R. 6390: To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of medical equipment to address the COVID-19 outbreak - Provisions related to the Defense Production Act H.R. 6410: To direct the President to use authority under the Defense Production Act of 1950 to ensure an adequate supply equipment necessary for limiting the spread of COVID-19 - Provisions related to the Defense Production Act H.R. 6450: Price Gouging Prevention Act - Provisions related to prescription drug and medical device pricing H.R. 6457: Disaster and Emergency Pricing Abuse Prevention Act - Provisions related to prescription drug and medical device pricing H.R. 6472: COVID-19 Price Gouging Prevention Act - Provisions related to prescription drug and medical device pricing HR6711, Medical Supply Transparency and Delivery Act, DPA impact on Rx manufacturers H.R. 6906: Health Care Emergency Guarantee Act - Provisions related to prescription drug access and cost sharing H.R. 7269: To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes - Provisions related to FDA provisional approval pathways H.R. 7288: To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development related to COVID-19, and for other purposes - Provisions related to prescription drug research and development and transparency H.R. 7296: To require any COVID-19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes - Provisions related to prescription drug pricing and transparency S. 61: Safe and Affordable Drugs from Canada Act of 2019 - Provisions related to importation S. 73: End Taxpayer Subsidies for Drug Ads Act - Provisions related to direct-to-consumer prescription drug advertising S. 658: Accelerated Drug Approval for Prescription Therapies Act or the ADAPT Act - Provisions related to accelerated approval S. 1384: Prescription Drug Rebate Reform Act of 2019 - Provisions related to prescription drug pricing and negotiated rebates S. 1391: FAIR Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and transparency S. 1437: Drug-price Transparency in Communications (DTC) Act - Provisions related to direct-to-consumer prescription drug advertising S. 1532: Pharmacy Benefit Manager Accountability Study Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1712: DISARM Act of 2019 - Provisions related to antimicrobial drug development S. 2161: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity S. 2304: Strategies To Address Antibiotic Resistance Act - Provisions related to antimicrobial resistance (AMR) and other issues S. 2723: Mitigating Emergency Drug Shortages Act - Provisions related to prescription drug pricing transparency and other provisions S. 3162: Affordable Drug Manufacturing Act of 2019 - Provisions related to prescription drug manufacturing S. 3166: Prescription Drug Affordability and Access Act - Provisions related to prescription drug pricing S. 3384: Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 - Provisions related to prescription drug price negotiation, importation, and other issues S. 3439: Lower Health Insurance Deductibles Act - Provisions related to prescription drug pricing and insurance plan design S. 3432: Securing America's Medicine Cabinet Act of 2020 - Provisions related to advanced manufacturing and prescription drugs S. 3545: Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Corona-virus Patients Act of 2020 - Provisions related to FDA prescription drug marketing approvals S3780, HOME Act S. 3872: Promising Pathway Act - Provisions related to FDA provisional approval pathways Transparency policy issues S. 3932: A bill to direct the Secretary of Defense to carry out a pilot program under the TRICARE pharmacy benefits program - Provisions related to DoD TRICARE pharmacy benefits program S. 4010: A bill to amend the Federal Food, Drug, and Cosmetic Act to make permanent the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases - Provisions related to priority review vouchers H.R. 7288: Taxpayer Research and Coronavirus Knowledge (TRACK) Act of 2020 - Provisions related to database of federal biomedical investment information for COVID-19 H.R. 7296: Make Medicines Affordable by Preventing Pandemic Pricegouging (MMAPPP) Act of 2020 Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020 (discussion draft) Proclamation Suspending Entry of Aliens Who Present a Risk to the U.S. Labor Market Following the Coronavirus Outbreak (June 22, 2020) Department of Homeland Security cybersecurity policy issues HHS PREP Act declaration relating to COVID-19 Drug cost and pricing policy issues Drug importation and counterfeiting policy issues HHS Safe Importation Action Plan Prescription drug take back and secure disposal policy issues Expanded access policy issues Antimicrobial resistance (AMR) policy issues High deductible health plans/HSA policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors FDA modernization policy issues PDUFA policy issues 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Foreign manufacturing policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Regulatory efficiencies policy issues COVID-19 policy issues Proposed Rule; Importation of Prescription Drugs (RIN 0910-AI45) Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients CARES ACT-Monograph Reform Support for Arthritis Caucus
2020 · second_quarter · Consumer Issues/Safety/Products
Data Privacy and Security - communications of retail views regarding data privacy and security issues, including IoT device security and proposed legislation affecting the collection, use and disclosure of personal information and self-regulatory privacy programs providing protection for consumers, including: S. 2968, Consumer Online Privacy Rights Act; S. 3456, Consumer Data Privacy & Security Act; S. 3663, COVID-19 Consumer Data Protection Act; S. 3749, Public Health Emergency Privacy Act; S. 3861, Exposure Notification Privacy Act; H.R. 2013, Information Transparency & Personal Data Control Act; H.R. 4978, Online Privacy Act; H.R. 6866, Public Health Emergency Privacy Act; Sen. Wicker staff discussion draft of the United States Consumer Data Privacy Act of 2019; and House Energy and Commerce Committee staff discussion draft of privacy legislation. Price-Gouging Issues - communications or retail views regarding price-gouging legislation, including: H.R. 6472, COVID-19 Price Gouging Prevention Act; S. 3574, Ending Price-Gouging During Emergencies Act; S. 3576, Disaster and Emergency Pricing Abuse Prevention Act; and Sen. Moran staff discussion draft of price-gouging legislation. CPSC Oversight issues - communications regarding data privacy issues; overall agency reviews on key issues.
Client expense: $1,560,000 · Firm income: Not reported
2020 · second_quarter · Consumer Issues/Safety/Products
H.R. 6472 - COVID-19 Price Gouging Prevention Act: Advocated for federal preemption and provided feedback on the bill and proposed changes to make it work well for retailers S. 6688: COVID-19 Consumer Data Protection Act of 2020, provided comments to the legislation as part of the Main Street Privacy Coalition S. 847 - Commercial Facial Recognition Privacy Act of 2019 Data Privacy, Congress interest in creating a national data privacy standard Recycling Leadership Council - recycling framework
Client expense: $350,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Federal Motor Carrier Safety Administration, Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT), White House Office
2020 · second_quarter · Health Issues
H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 985: FAST Generics Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 4100: DISARM Act of 2019 - Provisions related to antimicrobial drug development H.R. 5239: Prescription Drug Price Reporting Act - Provisions related to prescription drug pricing transparency H.R. 5668: MODERN Labeling Act of 2020 - Provisions related to prescription drug labeling H.R. 6080: Preventing Drug Shortages Act - Provisions related to prescription drug shortage reporting requirements H.R. 6222: Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6258: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity H.R. 6260: Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Coronavirus Patients Act of 2020 - Provisions related to FDA prescription drug marketing approvals H.R. 6390: Medical Supply Chain Emergency Act of 2020 - Provisions related to the Defense Production Act H.R. 6410: To direct the President to use authority under the Defense Production Act of 1950 to ensure an adequate supply equipment necessary for limiting the spread of COVID-19 - Provisions related to the Defense Production Act H.R. 6450: Price Gouging Prevention Act - Provisions related to prescription drug and medical device pricing H.R. 6457: Disaster and Emergency Pricing Abuse Prevention Act - Provisions related to prescription drug and medical device pricing H.R. 6472: COVID-19 Price Gouging Prevention Act - Provisions related to prescription drug and medical device pricing H.R. 6906: Health Care Emergency Guarantee Act - Provisions related to prescription drug access and cost sharing H.R. 7269: To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes - Provisions related to FDA provisional approval pathways H.R. 7288: Taxpayer Research and Coronavirus Knowledge Act of 2020 - Provisions related to prescription drug research and development and transparency H.R. 7296: MMAPPP Act of 2020 - Provisions related to prescription drug pricing and transparency S. 61: Safe and Affordable Drugs from Canada Act of 2019 - Provisions related to importation S. 73: End Taxpayer Subsidies for Drug Ads Act - Provisions related to direct-to-consumer prescription drug advertising S. 658: Accelerated Drug Approval for Prescription Therapies Act or the ADAPT Act - Provisions related to accelerated approval S. 1384: Prescription Drug Rebate Reform Act of 2019 - Provisions related to prescription drug pricing and negotiated rebates S. 1391: FAIR Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and transparency S. 1437: Drug-price Transparency in Communications (DTC) Act - Provisions related to direct-to-consumer prescription drug advertising S. 1532: Pharmacy Benefit Manager Accountability Study Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1712: DISARM Act of 2019 - Provisions related to antimicrobial drug development S. 2161: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity S. 2304: Strategies To Address Antibiotic Resistance Act - Provisions related to antimicrobial resistance (AMR) and other issues S. 2723: Mitigating Emergency Drug Shortages Act - Provisions related to prescription drug pricing transparency and other provisions S. 3162: Affordable Drug Manufacturing Act of 2019 - Provisions related to prescription drug manufacturing S. 3166: Prescription Drug Affordability and Access Act - Provisions related to prescription drug pricing S. 3384: Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 - Provisions related to prescription drug price negotiation, importation, and other issues S. 3439: Lower Health Insurance Deductibles Act - Provisions related to prescription drug pricing and insurance plan design S. 3545: Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Coronavirus Patients Act of 2020 - Provisions related to FDA prescription drug marketing approvals S. 3872: Promising Pathway Act - Provisions related to FDA provisional approval pathways S. 3932: TRICARE Retail Pharmacy Prescription Medication Expansion Act of 2020 - Provisions related to DoD TRICARE pharmacy benefits program S. 4010: Creating Hope Reauthorization Act - Provisions related to priority review vouchers Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020 (discussion draft) Proclamation Suspending Entry of Aliens Who Present a Risk to the U.S. Labor Market Following the Coronavirus Outbreak (June 22, 2020) Department of Homeland Security cybersecurity policy issues HHS PREP Act declaration relating to COVID-19 Drug cost and pricing policy issues Drug importation and counterfeiting policy issues HHS Safe Importation Action Plan Prescription drug take back and secure disposal policy issues Expanded access policy issues Antimicrobial resistance (AMR) policy issues High deductible health plans/HSA policy issues FDA modernization policy issues PDUFA policy issues 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Foreign manufacturing policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Regulatory efficiencies policy issues COVID-19 policy issues Proposed Rule; Importation of Prescription Drugs (RIN 0910-AI45) Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients
2020 · second_quarter · Consumer Issues/Safety/Products
price gouging, organized retail crime (ORC), marketplace transparency - S. 3431, HR. 6472; COVID-19/CARES Act
Client expense: $460,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Telecommunications & Information Administration (NTIA), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR), White House Office
2020 · second_quarter · Consumer Issues/Safety/Products
H.R.2, Moving Forward Act H.R.6256, Five-Stars for Safe Cars Act H.R.6284, 21st Century Smart Cars Act H.R.3773, Safe Roads Act of 2019 H.R.6800, The Heroes Act H.R.6472, COVID-19 Price Gouging Prevention Act S.3913, End Double Taxation of Successful Consumer Claims Act S.1767, Safe Sleep Act of 2019 S.1902, Stop Tip-overs of Unstable, Risky Dressers on Youth Act S.3824, Protecting Seniors from Emergency Scams Act Issues related to ridesharing safety Issues related to Consumer Product Safety Commission and National Highway Traffic Safety Administration oversights Issues related to the Department of Transportation unfair and deceptive practices Issues related to airline refunds Issues related to COVID-19 antitrust
Client expense: $50,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Transportation, Dept of (DOT)
2020 · second_quarter · Consumer Issues/Safety/Products
H.R. 6472, COVID-19 Price Gouging Prevention Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Consumer Issues/Safety/Products
1. H.R. 6472, COVID-19 Price Gouging Prevention Act, entire bill
Client expense: $80,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Pension & Welfare Benefits Administration, Pension Benefit Guaranty Corporation (PBGC), SENATE, Social Security Administration (SSA), U.S. Trade Representative (USTR)
2020 · first_quarter · Consumer Issues/Safety/Products
price gouging, organized retail crime (ORC), marketplace transparency - S. 3431, HR. 6472; COVID-19/CARES Act
Client expense: $530,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Telecommunications & Information Administration (NTIA), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR), White House Office
2020 · first_quarter · Consumer Issues/Safety/Products
price gouging, organized retail crime (ORC), marketplace transparency - S. 3431, HR. 6472; COVID-19/CARES Act
Client expense: $600,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Telecommunications & Information Administration (NTIA), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR), White House Office
2020 · first_quarter · Consumer Issues/Safety/Products
H.R.748, CARES Act H.R.6472, To prohibit price gouging in connection with the public health emergency resulting from COVID-19, and for other purposes H.R.2211, STURDY Act H.R.3172, Safe Sleep for Babies Act of 2019 H.R.5565, SHARE Information Act H.R.3248, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2019 S.1902, Stop Tip-overs of Unstable, Risky Dressers on Youth Act S.3431, INFORM Consumers Act H.R.6284, 21st Century Smart Cars Act H.R.6256, Five-Stars for Safe Cars Act Issues related to portable generator and automated vehicle safety Issues related to booster seat labeling Issues related to platform accountability Issues related to airline fee, family seating, and safety
Client expense: $40,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)
| Democratic |
| FL |
| David J. Trone | Democratic | MD |
| David N. Cicilline | Democratic | RI |
| David Scott | Democratic | GA |
| Diana DeGette | Democratic | CO |
| Eleanor Holmes Norton | Democratic | DC |
| Frank Pallone, Jr. | Democratic | NJ |
| Frederica S. Wilson | Democratic | FL |
| Gerald E. Connolly | Democratic | VA |
| Greg Stanton | Democratic | AZ |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| Jackie Speier | Democratic | CA |
| Jason Crow | Democratic | CO |
| Jerrold Nadler | Democratic | NY |
| John P. Sarbanes | Democratic | MD |
| Joseph P. Kennedy III | Democratic | MA |
| Lisa Blunt Rochester | Democratic | DE |
| Lizzie Fletcher | Democratic | TX |
| Mark Pocan | Democratic | WI |
| Paul Tonko | Democratic | NY |
| Peter A. DeFazio | Democratic | OR |
| Peter Welch | Democratic | VT |
| Raúl M. Grijalva | Democratic | AZ |
| Robin L. Kelly | Democratic | IL |
| Ruben Gallego | Democratic | AZ |
| Thomas R. Suozzi | Democratic | NY |
| Tim Ryan | Democratic | OH |
| Tony Cárdenas | Democratic | CA |
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Consumer Product Safety Commission (CPSC), Federal Maritime Commission, Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Maritime Administration (MARAD), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Postal Service (USPS), U.S. Trade Representative (USTR), White House Office
Client expense: $870,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Consumer Product Safety Commission (CPSC), Federal Maritime Commission, Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Maritime Administration (MARAD), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Postal Service (USPS), U.S. Trade Representative (USTR), White House Office
Client expense: $5,410,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)